|
|
neuron migration
|
GO:0001764 |
122 |
0.579
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.488
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.439
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.338
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.307
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.303
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.291
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.268
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.265
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.248
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.238
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.235
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.235
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.223
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.220
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.214
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.212
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.208
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.207
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.207
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.191
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.189
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.187
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.182
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.178
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.176
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.176
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.175
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.171
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.164
|
|
|
|
follicle stimulating hormone secretion
|
GO:0046884 |
1 |
0.164
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.161
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.159
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.158
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.153
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.153
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.150
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.149
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.149
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.144
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.144
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.144
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.141
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.140
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.140
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.137
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.136
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.128
|
Mouse |
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.126
|
Mouse |
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.126
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.125
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.125
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.124
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.123
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.121
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.121
|
|
|
|
subpallium neuron fate commitment
|
GO:0060163 |
2 |
0.121
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.120
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.118
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.117
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.115
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.114
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.109
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.107
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.106
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.105
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.104
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.104
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.101
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.097
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.096
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.095
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.094
|
|
|
|
regulation of female gonad development
|
GO:2000194 |
7 |
0.094
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.094
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.093
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.093
|
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
18 |
0.092
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.092
|
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.090
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.089
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.089
|
|
|
|
positive regulation of adenylate cyclase activity
|
GO:0045762 |
8 |
0.089
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.085
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.085
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.085
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.084
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.084
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.084
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.082
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.082
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.081
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.081
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.081
|
|
|
|
nephric duct elongation
|
GO:0035849 |
1 |
0.081
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.081
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.080
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.080
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.078
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.078
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.078
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.078
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.077
|
|
|
|
cell surface receptor signaling pathway involved in heart development
|
GO:0061311 |
15 |
0.077
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.076
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.075
|
Mouse |
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.075
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.074
|
Mouse |
|
|
water homeostasis
|
GO:0030104 |
27 |
0.073
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.073
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.073
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.073
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.072
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.072
|
Mouse |
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.071
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.071
|
Mouse |
|
|
trabecular meshwork development
|
GO:0002930 |
2 |
0.070
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.070
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.069
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.068
|
|
|
|
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0072108 |
3 |
0.068
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.067
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.066
|
|
|
|
dopaminergic neuron differentiation
|
GO:0071542 |
14 |
0.066
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.066
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.066
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.065
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.065
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.064
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.064
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.064
|
Mouse |
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.064
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.063
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.063
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.063
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.062
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.062
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.061
|
|
|
|
general adaptation syndrome
|
GO:0051866 |
2 |
0.061
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.060
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.060
|
Mouse |
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.059
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.059
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.059
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.058
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.058
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.058
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.057
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.057
|
Mouse |
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.056
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.056
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.056
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.055
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.055
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.054
|
|
|
|
mesenchymal to epithelial transition
|
GO:0060231 |
12 |
0.054
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.054
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.054
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.054
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.054
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.054
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.054
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.053
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.053
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.053
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.052
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.052
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.052
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.052
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.052
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.052
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.052
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.052
|
Mouse |
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.052
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.051
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.051
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.050
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.050
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.050
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.050
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.050
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.050
|
|
|
|
adrenal gland development
|
GO:0030325 |
18 |
0.049
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.049
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.049
|
|
|
|
adenylate cyclase inhibiting serotonin receptor signaling pathway
|
GO:0007198 |
1 |
0.048
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.048
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.047
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.047
|
Mouse |
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.047
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.047
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.047
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.046
|
Mouse |
|
|
positive regulation of epithelial cell differentiation involved in kidney development
|
GO:2000698 |
2 |
0.046
|
|
|
|
cellular response to ethanol
|
GO:0071361 |
3 |
0.045
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.045
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.045
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.045
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.045
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.045
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.045
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.044
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.044
|
|
|
|
horizontal cell localization
|
GO:0035852 |
1 |
0.044
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.044
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.043
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.043
|
Mouse |
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.043
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.043
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.043
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.042
|
|
|
|
motor neuron migration
|
GO:0097475 |
4 |
0.042
|
|
|
|
opioid receptor signaling pathway
|
GO:0038003 |
5 |
0.042
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.042
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.042
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900211 |
4 |
0.041
|
|
|
|
pericardium development
|
GO:0060039 |
16 |
0.041
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.041
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.041
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.041
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.041
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.041
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.040
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.040
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.040
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.040
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.040
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.040
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.040
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.040
|
|
|
|
organ induction
|
GO:0001759 |
21 |
0.040
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.040
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.040
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.039
|
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
8 |
0.039
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.039
|
|
|
|
female genitalia development
|
GO:0030540 |
14 |
0.039
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.038
|
|
|
|
uterine epithelium development
|
GO:0035847 |
1 |
0.038
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.038
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.038
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.037
|
|
|
|
cerebral cortex gabaergic interneuron differentiation
|
GO:0021892 |
9 |
0.037
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.037
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.037
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
28 |
0.036
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.036
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.036
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.036
|
|
|
|
oviduct epithelium development
|
GO:0035846 |
1 |
0.036
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.036
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.035
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.035
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.035
|
|
|
|
peyer s patch morphogenesis
|
GO:0061146 |
3 |
0.035
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.035
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.035
|
Mouse |
|
|
endocrine hormone secretion
|
GO:0060986 |
15 |
0.035
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.035
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.035
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.034
|
|
|
|
vagina development
|
GO:0060068 |
11 |
0.034
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.034
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.034
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.034
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.034
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.034
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.034
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.034
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.034
|
Mouse |
|
|
neuron fate determination
|
GO:0048664 |
9 |
0.033
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.033
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.033
|
Mouse |
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.033
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.033
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.032
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.032
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.032
|
Mouse |
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.032
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.032
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.032
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.031
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.031
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.031
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.031
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.031
|
|
|
|
regulation of adenylate cyclase activity
|
GO:0045761 |
10 |
0.031
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.031
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.031
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.031
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.031
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.031
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.031
|
|
|
|
urinary tract smooth muscle contraction
|
GO:0014848 |
6 |
0.030
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
24 |
0.030
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.030
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.030
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.030
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.030
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.030
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.030
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.030
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.029
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.029
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.029
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.029
|
|
|
|
positive regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033145 |
4 |
0.029
|
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.029
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.029
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.029
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.029
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.028
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.028
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.028
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.028
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.028
|
|
|
|
negative regulation of female gonad development
|
GO:2000195 |
3 |
0.028
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.028
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.028
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.028
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.028
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.028
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.027
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.027
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.027
|
|
|
|
negative regulation of adenylate cyclase activity
|
GO:0007194 |
1 |
0.027
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.027
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.027
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.027
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.027
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.027
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.027
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.027
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.027
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.026
|
|
|
|
positive regulation of actin filament bundle assembly
|
GO:0032233 |
11 |
0.026
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.026
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.026
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.026
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.026
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.026
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.026
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.026
|
|
|
|
mesonephric tubule formation
|
GO:0072172 |
11 |
0.026
|
|
|
|
mesodermal cell differentiation
|
GO:0048333 |
22 |
0.026
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.025
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.025
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.025
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.025
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.025
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.025
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.025
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.025
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.025
|
|
|
|
positive regulation of stress fiber assembly
|
GO:0051496 |
9 |
0.025
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.025
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.025
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.025
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.025
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.025
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.024
|
|
|
|
post anal tail morphogenesis
|
GO:0036342 |
23 |
0.024
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.024
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.024
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.024
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.024
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.024
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.024
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.024
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.024
|
|
|
|
regulation of lateral mesodermal cell fate specification
|
GO:0048378 |
2 |
0.023
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.023
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.023
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.023
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.023
|
|
|
|
positive regulation of anterior head development
|
GO:2000744 |
2 |
0.023
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.023
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.023
|
|
|
|
behavioral response to ethanol
|
GO:0048149 |
8 |
0.023
|
|
|
|
cell migration involved in heart development
|
GO:0060973 |
8 |
0.023
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.023
|
|
|
|
epithelial mesenchymal signaling involved in prostate gland development
|
GO:0060738 |
2 |
0.023
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.023
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.023
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.022
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.022
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.022
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.022
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.022
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.022
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.022
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.022
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.022
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.022
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.022
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.022
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.022
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.021
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.021
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.021
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.021
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.021
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.021
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.021
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.021
|
|
|
|
synaptic transmission glutamatergic
|
GO:0035249 |
36 |
0.021
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.021
|
|
|
|
rhombomere formation
|
GO:0021594 |
1 |
0.021
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.021
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.021
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.021
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.021
|
|
|
|
negative regulation of type b pancreatic cell apoptotic process
|
GO:2000675 |
3 |
0.021
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.021
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.021
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.021
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.020
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.020
|
|
|
|
auditory receptor cell differentiation
|
GO:0042491 |
37 |
0.020
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.020
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.020
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.020
|
|
|
|
renal vesicle development
|
GO:0072087 |
17 |
0.020
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.020
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.020
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.020
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.020
|
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.020
|
|
|
|
adenohypophysis development
|
GO:0021984 |
14 |
0.020
|
|
|
|
response to ethanol
|
GO:0045471 |
18 |
0.020
|
|
|
|
postganglionic parasympathetic nervous system development
|
GO:0021784 |
2 |
0.020
|
|
|
|
substrate independent telencephalic tangential interneuron migration
|
GO:0021843 |
8 |
0.020
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.020
|
|
|
|
biological phase
|
GO:0044848 |
20 |
0.020
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.020
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.019
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.019
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.019
|
|
|
|
general adaptation syndrome behavioral process
|
GO:0051867 |
1 |
0.019
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.019
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.019
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.019
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.019
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.019
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.019
|
|
|
|
serotonin receptor signaling pathway
|
GO:0007210 |
8 |
0.019
|
|
|
|
epithelial cell fate commitment
|
GO:0072148 |
13 |
0.019
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.019
|
|
|
|
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0003339 |
5 |
0.019
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.019
|
|
|
|
negative regulation of feeding behavior
|
GO:2000252 |
1 |
0.019
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.019
|
|
|
|
cerebral cortex neuron differentiation
|
GO:0021895 |
19 |
0.019
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.019
|
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.019
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.019
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.019
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.019
|
|
|
|
cerebral cortex gabaergic interneuron migration
|
GO:0021853 |
6 |
0.019
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.018
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.018
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.018
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.018
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.018
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.018
|
|
|
|
uterus development
|
GO:0060065 |
16 |
0.018
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.018
|
|
|
|
visceral motor neuron differentiation
|
GO:0021524 |
3 |
0.018
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.018
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.018
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.018
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.018
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.018
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.018
|
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.018
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.018
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.018
|
Mouse |
|
|
negative regulation of reproductive process
|
GO:2000242 |
31 |
0.018
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.018
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.018
|
|
|
|
granulocyte colony stimulating factor production
|
GO:0071611 |
1 |
0.018
|
|
|
|
regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061178 |
31 |
0.018
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.018
|
|